Patient Safety Organizations: Voluntary Relinquishment for Symbria SAFE, 59624-59625 [2019-24152]

Download as PDF 59624 Federal Register / Vol. 84, No. 214 / Tuesday, November 5, 2019 / Notices and Constitution Avenue NW, Washington, DC 20551–0001, not later than December 5, 2019. A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. Greene Investment Company, Jefferson, Iowa; to merge with Perry Investment Company and thereby indirectly acquire Raccoon Valley Bank, both of Perry, Iowa. Board of Governors of the Federal Reserve System, October 31, 2019. Michele Taylor Fennell, Assistant Secretary of the Board. [FR Doc. 2019–24130 Filed 11–4–19; 8:45 am] BILLING CODE 6210–01–P 77 K Street NE, 10th Floor, Washington, DC 20002 November 13, 2019, 8:30 a.m. Open Session 1. Approval of the October 28, 2019 Board Meeting Minutes 2. Investment Manager Annual Service Review 3. Investment Benchmark Update 4. Monthly Reports (a) Participant Activity Report (b) Investment Performance (c) Legislative Report 5. Quarterly Reports (d) Metrics 6. Office of Resource Management Annual Report and FEVS Update Closed Session Information covered under 5 U.S.C. 552b(c)(6). Contact Person for More Information: Kimberly Weaver, Director, Office of External Affairs, (202) 942–1640. BILLING CODE 6760–01–P khammond on DSKJM1Z7X2PROD with NOTICES GENERAL SERVICES ADMINISTRATION [Notice-MA–2019–09; Docket No. 2019– 0002; Sequence No. 26] DEPARTMENT OF HEALTH AND HUMAN SERVICES This bulletin reaffirms that sleeping in buildings under the jurisdiction, custody or control of GSA, including those buildings delegated to other Federal agencies by the Administrator of General Services, is prohibited, except when expressly authorized by an agency official. Sleeping may be authorized if the person is directed by a supervisor to remain in the building to conduct official government business and it is necessary for the person to sleep on the premises or, in the case of an emergency where there is imminent danger to human life or property, where persons are directed to shelter-in-place. Applicable: November 5, 2019. FOR FURTHER INFORMATION CONTACT: Board Member Meeting [FR Doc. 2019–24085 Filed 11–4–19; 8:45 am] Notice. SUMMARY: DATES: FEDERAL RETIREMENT THRIFT INVESTMENT BOARD Dated: October 30, 2019. Megan Grumbine, General Counsel, Federal Retirement Thrift Investment Board. ACTION: Chris Coneeney, Director, Real Property Policy Division, Office of Governmentwide Policy, GSA at 202–501–2956, or email realpropertypolicy@gsa.gov. Please cite FMR Bulletin B–49. The Federal Management Regulation (FMR) does not specifically identify unauthorized sleeping as a type of prohibited conduct in subpart C of 41 CFR part 102–74. Instead, agency officials have relied on provisions in the FMR that address hazards, disturbances and failure to comply with the lawful direction of Federal police officers and other authorized individuals to prohibit the practice of unofficially sleeping in Federal buildings. Since GSA has received questions regarding the permissibility of sleeping in Federal buildings, and the FMR does not specifically address this conduct, GSA is issuing this bulletin to reaffirm the fact that all persons are prohibited from sleeping in Federal buildings, except when such activity is expressly authorized by an agency official. The Facility Manager will post this bulletin in a conspicuous place in the building so that all persons in the building have constructive or actual notice of the policy. SUPPLEMENTARY INFORMATION: Jessica Salmoiraghi, Associate Administrator, Office of Government-wide Policy. [FR Doc. 2019–24102 Filed 11–4–19; 8:45 am] BILLING CODE 6820–14–P Federal Management Regulation (FMR); Sleeping in Federal Buildings Office of Government-wide Policy (OGP), General Services Administration (GSA). AGENCY: VerDate Sep<11>2014 16:34 Nov 04, 2019 Jkt 250001 PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 Agency for Healthcare Research and Quality Patient Safety Organizations: Voluntary Relinquishment for Symbria SAFE Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (HHS). ACTION: Notice of delisting. AGENCY: The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to list as a patient safety organization (PSO) an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. AHRQ accepted a notification of proposed voluntary relinquishment from Symbria SAFE, PSO number P0146, of its status as a PSO, and has delisted the PSO accordingly. SUMMARY: The delisting was effective at 12:00 Midnight ET (2400) on October 31, 2019. ADDRESSES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. Both directories can be accessed electronically at the following HHS website: http://www.pso.ahrq.gov/listed. FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B, Rockville, MD 20857; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; Email: pso@ahrq.hhs.gov. SUPPLEMENTARY INFORMATION: DATES: Background The Patient Safety Act, 42 U.S.C. 299b–21 to 299b–26, and the related Patient Safety Rule, 42 CFR part 3, published in the Federal Register on November 21, 2008, 73 FR 70732– 70814, establish a framework by which individuals and entities that meet the definition of provider in the Patient Safety Rule may voluntarily report information to PSOs listed by AHRQ, on a privileged and confidential basis, for E:\FR\FM\05NON1.SGM 05NON1 Federal Register / Vol. 84, No. 214 / Tuesday, November 5, 2019 / Notices khammond on DSKJM1Z7X2PROD with NOTICES the aggregation and analysis of patient safety events. The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity are to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule relating to the listing and operation of PSOs. The Patient Safety Rule authorizes AHRQ to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of PSOs. AHRQ has accepted a notification of proposed voluntary relinquishment from Symbria SAFE, a component entity of Symbria Inc., to voluntarily relinquish its status as a PSO. Accordingly, Symbria SAFE, P0146, was delisted effective at 12:00 Midnight ET (2400) on October 31, 2019. Symbria SAFE has patient safety work product (PSWP) in its possession. The PSO will meet the requirements of section 3.108(c)(2)(i) of the Patient Safety Rule regarding notification to providers that have reported to the PSO and of section 3.108(c)(2)(ii) regarding disposition of PSWP consistent with section 3.108(b)(3). According to section 3.108(b)(3) of the Patient Safety Rule, the PSO has 90 days from the effective date of delisting and revocation to complete the disposition of PSWP that is currently in the PSO’s possession. More information on PSOs can be obtained through AHRQ’s PSO website at http://www.pso.ahrq.gov. Virginia Mackay-Smith, Associate Director. [FR Doc. 2019–24152 Filed 11–4–19; 8:45 am] BILLING CODE 4160–90–P VerDate Sep<11>2014 16:34 Nov 04, 2019 Jkt 250001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of public meeting. AGENCY: This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Thursday, November 21, 2019, from 8:30 a.m. to 12:00 p.m. ADDRESSES: The meeting will be held at AHRQ, 5600 Fishers Lane, Rockville, Maryland, 20857. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427– 1456. For press-related information, please contact Bruce Seeman at (301) 427–1998 or Bruce.Seeman@ AHRQ.hhs.gov. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Thursday, November 7, 2019. The agenda, roster, and minutes will be available from Ms. Heather Phelps, Committee Management Officer, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms. Phelps’ phone number is (301) 427–1128. SUPPLEMENTARY INFORMATION: SUMMARY: I. Purpose In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App., this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality (the Council). The Council is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 59625 information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Thursday, November 21, 2019, the Council meeting will convene at 8:30 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting is open to the public and will be available via webcast at www.webconferences.com/ahrq. The meeting will begin with an update on AHRQ’s budget, programs and initiatives. The agenda will also include a discussion about the challenges and opportunities to leverage AHRQ’s CDS Connect to improve care and a conversation about the gaps and opportunities for improving care, with a focus on social determinants of health. The meeting will adjourn at 12:00 p.m. The final agenda will be available on the AHRQ website at www.AHRQ.gov no later than Thursday, November 14, 2019. Dated: October 30, 2019. Virginia L. Mackay-Smith, Associate Director. [FR Doc. 2019–24081 Filed 11–4–19; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Reporting of Pregnancy Success Rates From Assisted Reproductive Technology (ART) Programs; Clarifications and Corrections Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces clarifications for and correction to certain data collection fields, terminology, and definitions used for reporting of pregnancy success rates from assisted reproductive technology (ART) programs. This reporting is required by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA). SUMMARY: E:\FR\FM\05NON1.SGM 05NON1

Agencies

[Federal Register Volume 84, Number 214 (Tuesday, November 5, 2019)]
[Notices]
[Pages 59624-59625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24152]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Patient Safety Organizations: Voluntary Relinquishment for 
Symbria SAFE

AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department 
of Health and Human Services (HHS).

ACTION: Notice of delisting.

-----------------------------------------------------------------------

SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient 
Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to 
list as a patient safety organization (PSO) an entity that attests that 
it meets the statutory and regulatory requirements for listing. A PSO 
can be ``delisted'' by the Secretary if it is found to no longer meet 
the requirements of the Patient Safety and Quality Improvement Act of 
2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses 
to voluntarily relinquish its status as a PSO for any reason, or when a 
PSO's listing expires. AHRQ accepted a notification of proposed 
voluntary relinquishment from Symbria SAFE, PSO number P0146, of its 
status as a PSO, and has delisted the PSO accordingly.

DATES: The delisting was effective at 12:00 Midnight ET (2400) on 
October 31, 2019.

ADDRESSES: The directories for both listed and delisted PSOs are 
ongoing and reviewed weekly by AHRQ. Both directories can be accessed 
electronically at the following HHS website: http://www.pso.ahrq.gov/listed.

FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality 
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B, 
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone 
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local): 
(301) 427-1130; Email: [email protected].

SUPPLEMENTARY INFORMATION:

Background

    The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the 
related Patient Safety Rule, 42 CFR part 3, published in the Federal 
Register on November 21, 2008, 73 FR 70732-70814, establish a framework 
by which individuals and entities that meet the definition of provider 
in the Patient Safety Rule may voluntarily report information to PSOs 
listed by AHRQ, on a privileged and confidential basis, for

[[Page 59625]]

the aggregation and analysis of patient safety events.
    The Patient Safety Act authorizes the listing of PSOs, which are 
entities or component organizations whose mission and primary activity 
are to conduct activities to improve patient safety and the quality of 
health care delivery.
    HHS issued the Patient Safety Rule to implement the Patient Safety 
Act. AHRQ administers the provisions of the Patient Safety Act and 
Patient Safety Rule relating to the listing and operation of PSOs. The 
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that 
attests that it meets the statutory and regulatory requirements for 
listing. A PSO can be ``delisted'' if it is found to no longer meet the 
requirements of the Patient Safety Act and Patient Safety Rule, when a 
PSO chooses to voluntarily relinquish its status as a PSO for any 
reason, or when a PSO's listing expires. Section 3.108(d) of the 
Patient Safety Rule requires AHRQ to provide public notice when it 
removes an organization from the list of PSOs.
    AHRQ has accepted a notification of proposed voluntary 
relinquishment from Symbria SAFE, a component entity of Symbria Inc., 
to voluntarily relinquish its status as a PSO. Accordingly, Symbria 
SAFE, P0146, was delisted effective at 12:00 Midnight ET (2400) on 
October 31, 2019.
    Symbria SAFE has patient safety work product (PSWP) in its 
possession. The PSO will meet the requirements of section 
3.108(c)(2)(i) of the Patient Safety Rule regarding notification to 
providers that have reported to the PSO and of section 3.108(c)(2)(ii) 
regarding disposition of PSWP consistent with section 3.108(b)(3). 
According to section 3.108(b)(3) of the Patient Safety Rule, the PSO 
has 90 days from the effective date of delisting and revocation to 
complete the disposition of PSWP that is currently in the PSO's 
possession.
    More information on PSOs can be obtained through AHRQ's PSO website 
at http://www.pso.ahrq.gov.

Virginia Mackay-Smith,
Associate Director.
[FR Doc. 2019-24152 Filed 11-4-19; 8:45 am]
BILLING CODE 4160-90-P